002826 易明医药
已收盘 05-22 15:00:00
资讯
新帖
简况
异动快报：易明医药（002826）5月22日14点4分触及涨停板
证券之星 · 14:05
异动快报：易明医药（002826）5月22日14点4分触及涨停板
易明医药：截至2026年5月20日，本公司股东数为15,636户
证券之星 · 08:39
易明医药：截至2026年5月20日，本公司股东数为15,636户
易明医药（002826）172万股限售股将于5月21日解禁，占总股本0.9%
证券之星 · 05-21 08:01
易明医药（002826）172万股限售股将于5月21日解禁，占总股本0.9%
股市必读：易明医药（002826）5月18日披露最新机构调研信息
证券之星 · 05-19
股市必读：易明医药（002826）5月18日披露最新机构调研信息
易明医药(002826)5月8日股东户数1.61万户，较上期增加0.46%
证券之星 · 05-13
易明医药(002826)5月8日股东户数1.61万户，较上期增加0.46%
易明医药：截至2026年5月8日，本公司股东数为16,102户
证券之星 · 05-13
易明医药：截至2026年5月8日，本公司股东数为16,102户
股市必读：易明医药(002826)股东户数1.6万户，较上期减少3.2%
证券之星 · 05-11
股市必读：易明医药(002826)股东户数1.6万户，较上期减少3.2%
易明医药：截至2026年4月30日，本公司股东数为16,028户
证券之星 · 05-08
易明医药：截至2026年4月30日，本公司股东数为16,028户
易明医药最新公告：股东周战拟减持不超1%股份
证券之星 · 05-07
易明医药最新公告：股东周战拟减持不超1%股份
每周股票复盘：易明医药（002826）股东户数增2.94%
证券之星 · 05-03
每周股票复盘：易明医药（002826）股东户数增2.94%
图解易明医药年报：第四季度单季净利润同比增长163.24%
证券之星 · 04-28
图解易明医药年报：第四季度单季净利润同比增长163.24%
易明医药：截至2026年4月20日，本公司股东数为16,557户
证券之星 · 04-22
易明医药：截至2026年4月20日，本公司股东数为16,557户
易明医药：截至2026年4月10日股东数为16,084户
证券之星 · 04-14
易明医药：截至2026年4月10日股东数为16,084户
股市必读：易明医药(002826)股东户数1.6万户，较上期增加0.7%
证券之星 · 04-07
股市必读：易明医药(002826)股东户数1.6万户，较上期增加0.7%
易明医药：截至2026年3月31日，本公司股东数为15,976户
证券之星 · 04-02
易明医药：截至2026年3月31日，本公司股东数为15,976户
股市必读：易明医药(002826)股东户数1.59万户，较上期减少6.82%
证券之星 · 03-25
股市必读：易明医药(002826)股东户数1.59万户，较上期减少6.82%
股市必读：易明医药（002826）3月23日收盘跌7.47%，主力净流出1539.37万元
证券之星 · 03-24
股市必读：易明医药（002826）3月23日收盘跌7.47%，主力净流出1539.37万元
易明医药（002826）发布公司2026年限制性股票激励计划首次授予公告，3月11日股价下跌2.37%
证券之星 · 03-11
易明医药（002826）发布公司2026年限制性股票激励计划首次授予公告，3月11日股价下跌2.37%
易明医药（002826）披露2026年限制性股票激励计划获临时股东大会审议通过，3月10日股价下跌3.33%
证券之星 · 03-10
易明医药（002826）披露2026年限制性股票激励计划获临时股东大会审议通过，3月10日股价下跌3.33%
易明医药（002826）披露2026年限制性股票激励计划首次授予激励对象名单审核及公示情况说明，3月3日股价下跌0.62%
证券之星 · 03-03
易明医药（002826）披露2026年限制性股票激励计划首次授予激励对象名单审核及公示情况说明，3月3日股价下跌0.62%
暂无数据
公司概况
公司名称：
西藏易明西雅医药科技股份有限公司
所属行业：
医药制造业
上市日期：
2016-12-09
主营业务：
西藏易明西雅医药科技股份有限公司的主营业务是药品生产销售及药品市场推广服务。公司的主要产品是化学药、中成药。
发行价格：
6.06
{"stockData":{"symbol":"002826","market":"SZ","secType":"STK","nameCN":"易明医药","latestPrice":19.59,"timestamp":1779433422000,"preClose":17.81,"halted":0,"volume":12934200,"delay":0,"changeRate":0.0999,"floatShares":185000000,"shares":191000000,"eps":0.4901,"marketStatus":"已收盘","change":1.78,"latestTime":"05-22 15:00:00","open":17.89,"high":19.59,"low":17.55,"amount":244000000,"amplitude":0.1145,"askPrice":0,"askSize":0,"bidPrice":19.59,"bidSize":2662,"shortable":0,"etf":0,"ttmEps":0.4901,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779672600000},"marketStatusCode":5,"adr":0,"adjPreClose":17.81,"symbolType":"stock","openAndCloseTimeList":[[1779413400000,1779420600000],[1779426000000,1779433200000]],"highLimit":19.59,"lowLimit":16.03,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":190677750,"isCdr":false,"pbRate":4.05,"roa":"--","peRate":39.971434,"roe":"2.38%","epsLYR":0.5,"committee":0,"marketValue":3735000000,"turnoverRate":0.07,"status":0,"floatMarketCap":3618000000},"requestUrl":"/m/hq/s/002826/tweets","defaultTab":"tweets","newsList":[{"id":"2637939343","title":"异动快报：易明医药（002826）5月22日14点4分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2637939343","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637939343?lang=zh_cn&edition=full","pubTime":"2026-05-22 14:05","pubTimestamp":1779429937,"startTime":"0","endTime":"0","summary":"证券之星5月22日盘中消息，14点4分易明医药触及涨停板。其所属行业化学制药目前上涨。领涨股为科源制药。该股为西藏概念，中药，医药概念热股，当日西藏概念概念上涨1.03%，中药概念上涨0.67%，医药概念上涨0.26%。5月21日的资金流向数据方面，主力资金净流出810.65万元，占总成交额13.24%，游资资金净流入550.09万元，占总成交额8.99%，散户资金净流入260.56万元，占总成交额4.26%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200022194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0239","BK0033","002826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637365086","title":"易明医药：截至2026年5月20日，本公司股东数为15,636户","url":"https://stock-news.laohu8.com/highlight/detail?id=2637365086","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637365086?lang=zh_cn&edition=full","pubTime":"2026-05-22 08:39","pubTimestamp":1779410357,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)05月21日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，请问截止2026年5月20日公司股东人数是多少？易明医药回复：尊敬的投资者，您好。根据中登结算深圳分公司下发的股东名册，截至2026年5月20日，本公司股东数为15,636户。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200009121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0056","BK0033","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637749508","title":"易明医药（002826）172万股限售股将于5月21日解禁，占总股本0.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637749508","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637749508?lang=zh_cn&edition=full","pubTime":"2026-05-21 08:01","pubTimestamp":1779321716,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，易明医药于5月21日将有172.0万股限售股份解禁，为公司股权激励限售股份，占公司总股本0.9%。本次解禁后，公司还有597.84万股限售股份，占总股本3.14%。易明医药主营业务：自主生产药品业务,第三方合作药品业务,原料药业务,药品原材料销售业务,药品推广服务业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100007563.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0033","BK0239","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636900373","title":"股市必读：易明医药（002826）5月18日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2636900373","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636900373?lang=zh_cn&edition=full","pubTime":"2026-05-19 02:23","pubTimestamp":1779128590,"startTime":"0","endTime":"0","summary":"截至2026年5月18日收盘，易明医药报收于18.73元，上涨1.79%，换手率2.61%，成交量4.78万手，成交额8917.75万元。来自股本股东变化：截至2026年5月8日，公司股东数为16,102户。来自业绩披露要点：2025年公司实现营业收入63,627.20万元，同比下降2.39%；归母净利润9,258.07万元，同比上升101.57%。公司公告汇总公司董事会于2026年4月24日审议通过《关于2025年度利润分配预案的议案》，该预案尚需提交2025年年度股东大会审议，并在审议通过后两个月内实施。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900002458.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","002826","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635075642","title":"易明医药(002826)5月8日股东户数1.61万户，较上期增加0.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635075642","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635075642?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:28","pubTimestamp":1778664513,"startTime":"0","endTime":"0","summary":"证券之星消息，近日易明医药披露，截至2026年5月8日公司股东户数为1.61万户，较4月30日增加74.0户，增幅为0.46%。在化学制药行业个股中，易明医药股东户数低于行业平均水平，截至5月8日，化学制药行业平均股东户数为3.58万户。从股价来看，2026年4月30日至2026年5月8日，易明医药区间跌幅为1.69%，在此期间股东户数增加74.0户，增幅为0.46%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300031823.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","002826","BK0239","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635737672","title":"易明医药：截至2026年5月8日，本公司股东数为16,102户","url":"https://stock-news.laohu8.com/highlight/detail?id=2635737672","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635737672?lang=zh_cn&edition=full","pubTime":"2026-05-13 11:33","pubTimestamp":1778643219,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)05月12日在投资者关系平台上答复投资者关心的问题。投资者提问：请问2026年5月10日公司股东人数是多少？谢谢易明医药回复：尊敬的投资者，您好。根据中登结算深圳分公司最新下发的股东名册，截至2026年5月8日，本公司股东数为16,102户。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300017687.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0033","002826","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634425923","title":"股市必读：易明医药(002826)股东户数1.6万户，较上期减少3.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2634425923","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634425923?lang=zh_cn&edition=full","pubTime":"2026-05-11 02:06","pubTimestamp":1778436375,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，易明医药报收于19.17元，下跌0.47%，换手率3.22%，成交量5.88万手，成交额1.12亿元。来自股本股东变化：截至2026年4月30日，公司股东户数环比下降3.2%，户均持股升至1.19万股。股本股东变化股东户数变动近日易明医药披露，截至2026年4月30日公司股东户数为1.6万户，较4月20日减少529.0户，减幅为3.2%。周战先生承诺此前未违反相关股份锁定及减持承诺，本次减持符合其已披露的承诺内容。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100001002.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0239","BK0033","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633101784","title":"易明医药：截至2026年4月30日，本公司股东数为16,028户","url":"https://stock-news.laohu8.com/highlight/detail?id=2633101784","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633101784?lang=zh_cn&edition=full","pubTime":"2026-05-08 08:54","pubTimestamp":1778201651,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)05月07日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2026年4月30日公司的股东总数是多少？谢谢易明医药回复：尊敬的投资者，您好。根据中登结算深圳分公司下发的股东名册，截至2026年4月30日，本公司股东数为16,028户。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800007687.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","002826","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633142378","title":"易明医药最新公告：股东周战拟减持不超1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2633142378","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633142378?lang=zh_cn&edition=full","pubTime":"2026-05-07 20:19","pubTimestamp":1778156375,"startTime":"0","endTime":"0","summary":"易明医药(002826.SZ)公告称，持股5%以上股东周战计划自公告披露之日起15个交易日后的3个月内，以集中竞价或大宗交易方式减持公司股份不超过190万股，占公司总股本的1.00%，减持原因为个人资金需求。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700038039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","002826","BK0239","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632674291","title":"每周股票复盘：易明医药（002826）股东户数增2.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632674291","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632674291?lang=zh_cn&edition=full","pubTime":"2026-05-03 03:28","pubTimestamp":1777750091,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，易明医药报收于19.5元，较上周的20.29元下跌3.89%。本周，易明医药4月27日盘中最高价报20.33元。业绩披露要点：2026年一季报归母净利润1964.84万元，同比上升4.55%；扣非净利润同比上升88.33%。股本股东变化股东户数变动截至2026年4月20日，公司股东户数为1.66万户，较4月10日增加473.0户，增幅2.94%。户均持股数量由上期的1.19万股减少至1.15万股，户均持股市值为24.36万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300000690.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","002826","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630631996","title":"图解易明医药年报：第四季度单季净利润同比增长163.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630631996","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630631996?lang=zh_cn&edition=full","pubTime":"2026-04-28 01:26","pubTimestamp":1777310770,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药2025年年报显示，当年度公司主营收入6.36亿元，同比下降2.39%；归母净利润9258.07万元，同比上升101.57%；扣非净利润4899.0万元，同比上升165.58%；其中2025年第四季度，公司单季度主营收入1.47亿元，同比上升5.93%；单季度归母净利润1081.75万元，同比上升163.24%；单季度扣非净利润904.27万元，同比上升328.92%；负债率19.81%，投资收益349.67万元，财务费用-28.38万元，毛利率82.11%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800003973.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629095598","title":"易明医药：截至2026年4月20日，本公司股东数为16,557户","url":"https://stock-news.laohu8.com/highlight/detail?id=2629095598","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629095598?lang=zh_cn&edition=full","pubTime":"2026-04-22 11:30","pubTimestamp":1776828637,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)04月21日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，请问4月20日的股东人数是多少？易明医药回复：尊敬的投资者，您好。根据中登结算深圳分公司下发的股东名册，截至2026年4月20日，本公司股东数为16,557户。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200025502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","002826","BK0239","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627167434","title":"易明医药：截至2026年4月10日股东数为16,084户","url":"https://stock-news.laohu8.com/highlight/detail?id=2627167434","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627167434?lang=zh_cn&edition=full","pubTime":"2026-04-14 16:36","pubTimestamp":1776155767,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)04月14日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截止到2026年4月10日公司股东人数是多少？谢谢！易明医药回复：尊敬的投资者，您好。根据中登结算深圳分公司下发的股东名册，截至2026年4月10日，本公司股东数为16,084户。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041400026272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0033","BK0239","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625609362","title":"股市必读：易明医药(002826)股东户数1.6万户，较上期增加0.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625609362","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625609362?lang=zh_cn&edition=full","pubTime":"2026-04-07 03:42","pubTimestamp":1775504532,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，易明医药报收于20.0元，下跌3.01%，换手率2.45%，成交量4.27万手，成交额8630.78万元。交易信息汇总资金流向4月3日主力资金净流出351.29万元，占总成交额4.07%；游资资金净流入217.61万元，占总成交额2.52%；散户资金净流入133.68万元，占总成交额1.55%。股本股东变化股东户数变动近日易明医药披露，截至2026年3月31日公司股东户数为1.6万户，较3月20日增加111.0户，增幅为0.7%。户均持股数量由上期的1.2万股减少至1.19万股，户均持股市值为23.81万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700002335.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0056","002826","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624575372","title":"易明医药：截至2026年3月31日，本公司股东数为15,976户","url":"https://stock-news.laohu8.com/highlight/detail?id=2624575372","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624575372?lang=zh_cn&edition=full","pubTime":"2026-04-02 15:00","pubTimestamp":1775113257,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)04月01日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘:您好！ 麻烦您告知公司截止3月31日的股东人数，谢谢！易明医药回复：尊敬的投资者，您好。根据中登结算深圳分公司下发的股东名册，截至2026年3月31日，本公司股东数为15,976户。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200019101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0033","BK0239","002826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622097060","title":"股市必读：易明医药(002826)股东户数1.59万户，较上期减少6.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622097060","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622097060?lang=zh_cn&edition=full","pubTime":"2026-03-25 02:43","pubTimestamp":1774377791,"startTime":"0","endTime":"0","summary":"截至2026年3月24日收盘，易明医药报收于19.21元，上涨6.25%，换手率4.62%，成交量8.06万手，成交额1.5亿元。交易信息汇总资金流向3月24日主力资金净流入224.2万元；游资资金净流出915.21万元；散户资金净流入691.01万元。股本股东变化股东户数变动近日易明医药披露，截至2026年3月20日公司股东户数为1.59万户，较3月10日减少1161.0户，减幅为6.82%。户均持股数量由上期的1.12万股增加至1.2万股，户均持股市值为23.48万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500003933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0033","BK0239","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621650085","title":"股市必读：易明医药（002826）3月23日收盘跌7.47%，主力净流出1539.37万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621650085","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621650085?lang=zh_cn&edition=full","pubTime":"2026-03-24 01:58","pubTimestamp":1774288692,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，易明医药报收于18.08元，下跌7.47%，换手率4.82%，成交量8.41万手，成交额1.56亿元。当日关注点来自交易信息汇总：易明医药股价连续3日下跌，累计跌幅达18.41%，主力资金前10个交易日累计净流出超5151万元。来自交易信息汇总：3月23日易明医药收盘报18.08元，下跌7.47%，当日成交额为841.04万元。来自资金流向：3月23日主力资金净流出1539.37万元，而游资与散户资金分别净流入1314.14万元和225.22万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400001814.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","002826","BK0239","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618492542","title":"易明医药（002826）发布公司2026年限制性股票激励计划首次授予公告，3月11日股价下跌2.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618492542","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618492542?lang=zh_cn&edition=full","pubTime":"2026-03-11 22:37","pubTimestamp":1773239836,"startTime":"0","endTime":"0","summary":"截至2026年3月11日收盘，易明医药报收于20.99元，较前一交易日下跌2.37%，最新总市值为40.02亿元。该股当日开盘21.73元，最高21.8元，最低20.81元，成交额达2亿元，换手率为5.45%。近日，易明医药披露《关于向2026年限制性股票激励计划激励对象首次授予限制性股票的公告》。本次激励计划拟授予总量为340.38万股，其中首次授予占比82.26%，预留17.74%。限售期为12个月，分两期各解除限售50%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100039673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","002826","BK0239","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618959610","title":"易明医药（002826）披露2026年限制性股票激励计划获临时股东大会审议通过，3月10日股价下跌3.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618959610","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618959610?lang=zh_cn&edition=full","pubTime":"2026-03-10 22:15","pubTimestamp":1773152121,"startTime":"0","endTime":"0","summary":"截至2026年3月10日收盘，易明医药报收于21.5元，较前一交易日下跌3.33%，最新总市值为41亿元。该股当日开盘22.43元，最高22.55元，最低21.0元，成交额达3.06亿元，换手率为8.15%。近日，西藏易明西雅医药科技股份有限公司发布《2026年第一次临时股东会决议公告》。关联股东对相关议案回避表决。会议召集、召开程序合法合规，表决结果有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031000038304.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","002826","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616332166","title":"易明医药（002826）披露2026年限制性股票激励计划首次授予激励对象名单审核及公示情况说明，3月3日股价下跌0.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616332166","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616332166?lang=zh_cn&edition=full","pubTime":"2026-03-03 22:59","pubTimestamp":1772549952,"startTime":"0","endTime":"0","summary":"近日，西藏易明西雅医药科技股份有限公司披露《董事会薪酬与考核委员会关于公司2026年限制性股票激励计划首次授予激励对象名单的审核意见及公示情况说明》。公告显示，公司于2026年2月10日召开董事会及薪酬与考核委员会会议，审议通过《2026年限制性股票激励计划（草案）》；并于2026年2月12日至2月21日在内部企业微信群公示了首次授予激励对象的姓名和职务，公示期间未收到异议。激励对象主体资格合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300044801.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0033","BK0056","002826"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779434269953,"stockEarnings":[{"period":"1week","weight":-0.0404},{"period":"1month","weight":-0.1559},{"period":"3month","weight":-0.1227},{"period":"6month","weight":-0.0352},{"period":"1year","weight":0.5351},{"period":"ytd","weight":-0.031}],"compareEarnings":[{"period":"1week","weight":-0.0241},{"period":"1month","weight":-0.0019},{"period":"3month","weight":-0.0012},{"period":"6month","weight":0.0632},{"period":"1year","weight":0.2036},{"period":"ytd","weight":0.0273}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"西藏易明西雅医药科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"15636人(较上一季度减少2.89%)","perCapita":"11812股","listingDate":"2016-12-09","address":"西藏自治区拉萨市堆龙德庆区经济技术开发区林琼岗路6号","registeredCapital":"19067万元","survey":" 西藏易明西雅医药科技股份有限公司的主营业务是药品生产销售及药品市场推广服务。公司的主要产品是化学药、中成药。","listedPrice":6.06},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"易明医药(002826)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供易明医药(002826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"易明医药,002826,易明医药股票,易明医药股票老虎,易明医药股票老虎国际,易明医药行情,易明医药股票行情,易明医药股价,易明医药股市,易明医药股票价格,易明医药股票交易,易明医药股票购买,易明医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"易明医药(002826)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供易明医药(002826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}